DASATINIB

DASATINIB (12842X)

Supply only until 01/10/2027
dasatinib 100 mg tablet, 30
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17833)

Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment - third-line therapy
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 5 DPMQ: $285.85 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
DASATINIB-TEVA
Dasatinib ARX
Dasatinib Dr.Reddy's
Dasatinib SUN
Dasatinib Sandoz
Dasatinib Viatris
Sprycel
dasatinib 50 mg tablet, 60
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 19225)

Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 5 DPMQ: $285.85 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
DASATINIB-TEVA
Dasatinib ARX
Dasatinib Dr.Reddy's
Dasatinib SUN
Dasatinib Sandoz
Dasatinib Viatris
MSN Dasatinib
Sprycel

DASATINIB (12849G)

Supply only until 01/10/2027
dasatinib 20 mg tablet, 60
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Initial treatment - third-line therapy
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 5 DPMQ: $177.22 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
DASATINIB-TEVA
Dasatinib ARX
Dasatinib Dr.Reddy's
Dasatinib SUN
Dasatinib Sandoz
Dasatinib Viatris
Sprycel

DASATINIB (12850H)

Supply only until 01/10/2027
dasatinib 20 mg tablet, 60
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17922)

Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment - second-line therapy
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 5 DPMQ: $177.22 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
DASATINIB-TEVA
Dasatinib ARX
Dasatinib Dr.Reddy's
Dasatinib SUN
Dasatinib Sandoz
Dasatinib Viatris
Sprycel

DASATINIB (12857Q)

Supply only until 01/10/2027
dasatinib 50 mg tablet, 60
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17833)

Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment - third-line therapy
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 5 DPMQ: $285.85 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
DASATINIB-TEVA
Dasatinib ARX
Dasatinib Dr.Reddy's
Dasatinib SUN
Dasatinib Sandoz
Dasatinib Viatris
Sprycel

DASATINIB (12859T)

Supply only until 01/10/2027
dasatinib 100 mg tablet, 30
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17922)

Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment - second-line therapy
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 5 DPMQ: $285.85 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
DASATINIB-TEVA
Dasatinib ARX
Dasatinib Dr.Reddy's
Dasatinib SUN
Dasatinib Sandoz
Dasatinib Viatris
Sprycel

DASATINIB (12860W)

Supply only until 01/10/2027
dasatinib 50 mg tablet, 60
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17922)

Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment - second-line therapy
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 5 DPMQ: $285.85 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
DASATINIB-TEVA
Dasatinib ARX
Dasatinib Dr.Reddy's
Dasatinib SUN
Dasatinib Sandoz
Dasatinib Viatris
Sprycel

DASATINIB (12865D)

Supply only until 01/10/2027
dasatinib 50 mg tablet, 60
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Initial treatment - third-line therapy
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 5 DPMQ: $285.85 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
DASATINIB-TEVA
Dasatinib ARX
Dasatinib Dr.Reddy's
Dasatinib SUN
Dasatinib Sandoz
Dasatinib Viatris
Sprycel

DASATINIB (12866E)

Supply only until 01/10/2027
dasatinib 70 mg tablet, 60
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 17833)

Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment - third-line therapy
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 5 DPMQ: $351.66 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
DASATINIB-TEVA
Dasatinib ARX
Dasatinib Dr.Reddy's
Dasatinib SUN
Dasatinib Sandoz
Dasatinib Viatris
Sprycel
dasatinib 20 mg tablet, 60
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 19225)

Indication: Chronic Myeloid Leukaemia (CML)
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 5 DPMQ: $177.22 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
DASATINIB-TEVA
Dasatinib ARX
Dasatinib Dr.Reddy's
Dasatinib SUN
Dasatinib Sandoz
Dasatinib Viatris
MSN Dasatinib
Sprycel